Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06892561 · ClinicalTrials.gov registry record
Phase-Aligned Atrial Fibrillation Mapping
A clinical trial of Atrial Fibrillation (AF), sponsored by Larisa Tereshchenko, MD, PhD.
- Active
- Registry status
- 336
- Enrollment target
- 1
- Study location
NCT06892561: Active study of Atrial Fibrillation (AF), sponsored by Larisa Tereshchenko, MD, PhD.
NCT06892561 is a study of Atrial Fibrillation (AF) that is active but no longer recruiting, run by Larisa Tereshchenko, MD, PhD. The registered enrollment target is 336 participants, below the 700-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06892561, a study of Atrial Fibrillation (AF), is active but no longer recruiting, sponsored by Larisa Tereshchenko, MD, PhD.
- ACTIVE NOT RECRUITING
- Registry status
- 336 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiac arrhythmia in the upper chamber of the heart (atrial fibrillation) can be cured by burning. Physicians burn very small pieces of abnormal tissue. It is important to know where to burn. The investigators propose a new way to find out where to burn. The investigators will use a new way to analyze electrical signals inside the heart and build a new electric map. The study may lead to the development of new technology. In the future, novel technology may increase the success rate and the number of cured atrial fibrillation patients. This study is a retrospective study of data collected during routine clinical care: atrial fibrillation ablations. The investigators will compare intracardiac electrograms and atrial activation maps in patients who had successful ablation outcomes (no recurrence within 1 year) and those who experienced a recurrence of arrhythmia within 1 year after the procedure.
Primary Outcome
Cases are defined as successful persistent AF ablation cases (documented freedom from AF during ≥1 year after ablation). Controls are defined as failed persistent AF ablation (recurrent, persistent AF in patients with documented well-isolated pulmonary veins).
Conditions Studied
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2023-08-16 |
| Est. Completion | 2026-08-16 |
What the registry record for NCT06892561 still lists
NCT06892561 is an observational study that tracks outcomes without assigning an intervention. The registered 336 participants enrollment target is mid-sized for trials with a published cap, below the 700-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Atrial Fibrillation (AF) appearing as the primary indexed condition, and to 0 interventions.
NCT06892561 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06892561 about?
NCT06892561 is a clinical study titled "Phase-Aligned Atrial Fibrillation Mapping". Cardiac arrhythmia in the upper chamber of the heart (atrial fibrillation) can be cured by burning. Physicians burn very small pieces of abnormal tissue. It is important to know where to burn. The investigators propose a new way to find out where to burn. The investigators will use a new way to anal...
What is the current status of trial NCT06892561?
This trial is currently active not recruiting. The enrollment target is 336 participants. The study started on 2023-08-16. Estimated completion is 2026-08-16.
What conditions does trial NCT06892561 study?
This clinical trial studies the following conditions: Atrial Fibrillation (AF).
Who is sponsoring clinical trial NCT06892561?
This trial is sponsored by Larisa Tereshchenko, MD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06892561 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation (AF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06892561's enrollment target sits among peer trials
336 12th of 17 higher than 6 of 17 other Atrial Fibrillation (AF) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation (AF) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity
RECRUITING · NA
-
Incidence of Long-TeRm Atrial Fibrillation After Acute Illness
RECRUITING
-
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
RECRUITING · NA
-
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
RECRUITING
-
Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.
RECRUITING
-
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- NCT03977207 · 336 participants · NA
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- NCT04665206 · 336 participants · Phase 1
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- NCT05124457 · 336 participants · Phase 2
DETERMINE: Detemir vs NPH
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI